Aortopathy and regurgitation in bicuspid valve patients increase the risk of aortopathy in relatives.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 07 2019
Historique:
received: 31 10 2018
revised: 12 02 2019
accepted: 15 03 2019
pubmed: 8 4 2019
medline: 13 2 2020
entrez: 8 4 2019
Statut: ppublish

Résumé

Bicuspid aortic valve (BAV) is the most frequent cardiac congenital valvular disease. Although the BAV risk of first degree relatives (FDR) has been assessed (7-9%), there is little information as to the heritable risk for aortopathy. Identify the specific risk for regional aortopathy in FDR with tricuspid aortic valve (TAV) of BAV patients according to their aortic phenotype and aortic regurgitation (AR). Using an international consortium, BAV probands were assessed for aortopathy of the root, ascending aorta and for AR. Aortopathy was defined by the presence of segmental dilatation. The presence of segmental aortopathy and AR in BAV probands was evaluated as predictor for aortopathy in FDR with TAV. We identified 74 FDR related to 49 probands with aortopathy and 66 FDR related to 31 probands without aortopathy. Demographic variables were similar between proband groups. Among FDR, 16 individuals had BAV (11.4%). TAV-FDR of probands with ascending aortopathy had higher incidence of root aortopathy (18.8% vs. 3.6% p < 0.05) while TAV-FDR of probands with root aortopathy had higher incidence of aortopathy at all aortic segments (55%vs25%, 55%vs21%, and 4%vs29% at annulus, root and ascending respectively, p < 0.05 for all). Independent predictors for root aortopathy in TAV-FDR were: ascending (OR = 6.23;95%CI:1.27-30.5) and root aortopathy (OR = 9.00;95%CI:1.58-51.1) in probands; and for ascending aortopathy: root aortopathy (OR = 4.04;95%CI:1.33-12.3) and AR in probands (OR = 4.84; 95%CI:1.75-13.4). Root and ascending aortopathy in BAV probands are strong predictors of aortopathy in their TAV-FDR. AR in BAV patients has an independent effect on the risk for ascending aortopathy in TAV-FDR.

Sections du résumé

BACKGROUND
Bicuspid aortic valve (BAV) is the most frequent cardiac congenital valvular disease. Although the BAV risk of first degree relatives (FDR) has been assessed (7-9%), there is little information as to the heritable risk for aortopathy.
OBJECTIVE
Identify the specific risk for regional aortopathy in FDR with tricuspid aortic valve (TAV) of BAV patients according to their aortic phenotype and aortic regurgitation (AR).
METHODS
Using an international consortium, BAV probands were assessed for aortopathy of the root, ascending aorta and for AR. Aortopathy was defined by the presence of segmental dilatation. The presence of segmental aortopathy and AR in BAV probands was evaluated as predictor for aortopathy in FDR with TAV.
RESULTS
We identified 74 FDR related to 49 probands with aortopathy and 66 FDR related to 31 probands without aortopathy. Demographic variables were similar between proband groups. Among FDR, 16 individuals had BAV (11.4%). TAV-FDR of probands with ascending aortopathy had higher incidence of root aortopathy (18.8% vs. 3.6% p < 0.05) while TAV-FDR of probands with root aortopathy had higher incidence of aortopathy at all aortic segments (55%vs25%, 55%vs21%, and 4%vs29% at annulus, root and ascending respectively, p < 0.05 for all). Independent predictors for root aortopathy in TAV-FDR were: ascending (OR = 6.23;95%CI:1.27-30.5) and root aortopathy (OR = 9.00;95%CI:1.58-51.1) in probands; and for ascending aortopathy: root aortopathy (OR = 4.04;95%CI:1.33-12.3) and AR in probands (OR = 4.84; 95%CI:1.75-13.4).
CONCLUSION
Root and ascending aortopathy in BAV probands are strong predictors of aortopathy in their TAV-FDR. AR in BAV patients has an independent effect on the risk for ascending aortopathy in TAV-FDR.

Identifiants

pubmed: 30954286
pii: S0167-5273(18)36321-6
doi: 10.1016/j.ijcard.2019.03.031
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-120

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Victor Dayan (V)

Centro Cardiovascular Universitario, Hospital de Clinicas, Universidad de la República, Montevideo, Uruguay. Electronic address: victor_dayan@hotmail.com.

Ana Zuasnabar (A)

Centro Cardiovascular Universitario, Hospital de Clinicas, Universidad de la República, Montevideo, Uruguay.

Rodolfo Citro (R)

Heart Department, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.

Eduardo Bossone (E)

Heart Department, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.

Hector I Michelena (HI)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States of America.

Gabriel Parma (G)

Centro Cardiovascular Universitario, Hospital de Clinicas, Universidad de la República, Montevideo, Uruguay.

Michele Bellino (M)

Heart Department, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.

Alicia Olascoaga (A)

Departamento de Laboratorio Clinico, Hospital de Clínicas, Universidad de la Republica, Montevideo, Uruguay.

Lucia Florio (L)

Centro Cardiovascular Universitario, Hospital de Clinicas, Universidad de la República, Montevideo, Uruguay.

Simon Body (S)

Department of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH